Last reviewed · How we verify

CT-guided corticosteroid+ bupivicaine — Competitive Intelligence Brief

CT-guided corticosteroid+ bupivicaine (CT-guided corticosteroid+ bupivicaine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid + local anesthetic combination injection. Area: Pain Management / Rheumatology / Interventional Medicine.

marketed Corticosteroid + local anesthetic combination injection Pain Management / Rheumatology / Interventional Medicine Small molecule Live · refreshed every 30 min

Target snapshot

CT-guided corticosteroid+ bupivicaine (CT-guided corticosteroid+ bupivicaine) — Montefiore Medical Center. A CT-guided injection combining a corticosteroid and local anesthetic to reduce inflammation and provide pain relief at a targeted anatomical site.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
CT-guided corticosteroid+ bupivicaine TARGET CT-guided corticosteroid+ bupivicaine Montefiore Medical Center marketed Corticosteroid + local anesthetic combination injection

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid + local anesthetic combination injection class)

  1. Montefiore Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CT-guided corticosteroid+ bupivicaine — Competitive Intelligence Brief. https://druglandscape.com/ci/ct-guided-corticosteroid-bupivicaine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: